News – Page 146 – Endpoints News

Arrowhead plots next steps for RNAi therapies after mid-stage win in mixed hyperlipidemia

11 months ago

Biohaven’s autoimmune drug disappoints investors in study of healthy volunteers

11 months ago

J&J's major depressive disorder drug hits endpoints in Phase 3 trial

11 months ago

Insmed, Merus announce public offerings; AI startup raises $13M seed round

11 months ago

New York startup raises $33M for fertility treatment based on George Church’s stem cell research

11 months ago

Bristol Myers pays $80M to license another Prothena neuroscience candidate

11 months ago

Ikena Oncology weighs ‘strategic options’ as it drops cancer asset, trims headcount to save cash

11 months ago

Arcturus teases data from small trial of inhalable cystic fibrosis mRNA therapy, stock rockets

11 months ago

Merck returns to lucrative eye disease market in up to $3B deal for EyeBio

11 months ago

AstraZeneca reveals early data for oral PCSK9, touts PK edge over Merck’s drug

11 months ago

NIH-funded trials often miss diversity targets, small study shows

11 months ago

FDA details new 'platform technology' process that could accelerate cell and gene therapy approvals

11 months ago

NIH officials used personal emails, tweaked words to skirt FOIA searches during pandemic, lawmakers find

11 months ago

GLP-1 prescriptions reach all-time high as Lilly and Novo scramble to keep pace with demand

11 months ago

Canadian biotech VC Amplitude raises $192M second fund

11 months ago

Louisiana governor signs law limiting ability of doctors to prescribe abortion medications

11 months ago

Joe Panetta to step down as Biocom California CEO

11 months ago

Second engineered B cell therapy enters the clinic, promising to do in hemophilia B what gene therapies can't

11 months ago

Insmed stock skyrockets on Phase 3 lung disease data

11 months ago

Agios sells rights to glioma drug to Royalty Pharma; Cargo’s $110M placement

11 months ago

J&J makes another I&I acquisition with $1.25B deal for Numab's Yellow Jersey

11 months ago

NewAmsterdam says former Amgen cardio drug reduces heart disease risk factor

11 months ago

Takeda to lay off 640 workers in Massachusetts as part of multiyear overhaul

11 months ago

Duchenne muscular dystrophy drug flunks Phase 3 confirmatory trial

11 months ago

First page Previous page 143 144 145146147 148 149 Next page Last page